Infectious Diseases and Therapy

Aims & Scope

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices.

Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 5,500.00 EUR. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

  Citation: 367

  Authors: Richard G., Evangelos J., Galia, Amy J., Matteo, Jose, Oliver A., Joseph, Tanaya, Jihad, George L., Tim, Maria Jose Lopez, Eun Jeong, Francesco, Ilana, Elizabeth L., David, Olga, Jeffery, Shu, Michael N., Keith S.

• A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19

  Citation: 321

  Authors: Sonia N., Davide, Victoria R., Josep

• In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens

  Citation: 280

  Authors: Maren, Torsten, Markus, Juergen

• Infections in Cancer Patients with Solid Tumors: A Review

  Citation: 259

  Authors: Kenneth V. I.

• Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections

  Citation: 249

  Authors: Francelise B., João Luiz, Rogério R., Flávio

• Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

  Citation: 229

  Authors: Louis, Paul A., Brigitte, Josep, Paolo, Bosco, Eric A. F., Xavier

• Climate Change and Cascading Risks from Infectious Disease

  Citation: 198

  Authors: Jan C., Joacim, Kristie L.

• Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa

  Citation: 197

  Authors: Ashlan J., Amer, Dana, Nicholas, Michael J.

• Rapid and Effective Virucidal Activity of Povidone-Iodine Products Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Modified Vaccinia Virus Ankara (MVA)

  Citation: 179

  Authors: Maren, Markus, Juergen

• The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood

  Citation: 169

  Authors: Brigitte, Eric A. F., Paul A., Bosco, Josep, Paolo, Louis, Xavier